BridgeBio Pharma Inc. (BBIO) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    BridgeBio Pharma Inc.

    NASDAQ: BBIO · Real-Time Price · USD
    50.05
    1.05 (2.14%)
    At close: Sep 26, 2025, 3:59 PM
    50.00
    -0.10%
    After-hours: Sep 26, 2025, 07:55 PM EDT

    BridgeBio Pharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 221.9M 9.3M 77.65M 69.72M
    Cost of Revenue
    		 3.88M 2.45M 3.43M 3.11M
    Gross Profit
    		 218.02M 6.86M 74.21M 66.6M
    Operating Income
    		 -592.97M -607.37M -471.87M -579.75M
    Interest Income
    		 17.25M 18.04M 7.54M 1.13M
    Pretax Income
    		 -542.19M -653.25M -484.65M -586.45M
    Net Income
    		 -535.76M -643.2M -481.18M -562.54M
    Selling & General & Admin
    		 288.93M 150.59M 143.19M 192.21M
    Research & Development
    		 506.46M 455.71M 402.9M 454.14M
    Other Expenses
    		 15.61M 7.93M n/a n/a
    Operating Expenses
    		 811M 614.23M 546.09M 646.35M
    Interest Expense
    		 99.29M 81.29M 80.44M 46.78M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 814.88M 616.67M 546.09M 646.35M
    Income Tax Expense
    		 1.15M n/a n/a n/a
    Shares Outstanding (Basic)
    		 186.08M 162.79M 147.47M 144.36M
    Shares Outstanding (Diluted)
    		 186.08M 162.79M 147.47M 144.36M
    EPS (Basic)
    		 -2.88 -3.95 -3.35 -4.43
    EPS (Diluted)
    		 -2.88 -3.95 -3.35 -4.43
    EBITDA
    		 -436.83M -565.47M -397.44M -533.83M
    EBIT
    		 -442.9M -571.96M -404.21M -539.68M
    Depreciation & Amortization
    		 6.08M 6.49M 6.77M 5.84M

    Add to Watchlist